Alpha Lipoic Acid 300mg Capsules

Alpha-lipoic acid (ALA) is a mitochondria-synthesised antioxidant with unique dual solubility in both water and fat — allowing it to neutralise free radicals in virtually every tissue compartment of the body, unlike purely water-soluble vitamin C or fat-soluble vitamin E. MSVD Labs’ Alpha Lipoic Acid 300mg Capsules deliver a high-potency therapeutic dose used clinically for diabetic neuropathy management, metabolic syndrome support, and broad-spectrum antioxidant protection. ALA’s primary clinical application is peripheral diabetic neuropathy — painful nerve damage caused by chronic hyperglycaemia. Multiple randomised controlled trials have demonstrated that 600mg ALA daily improves neuropathic symptom scores including burning, pain, numbness, and tingling within 3–5 weeks. Germany’s healthcare system has approved intravenous ALA therapy for diabetic neuropathy for over 30 years, with extensive safety and efficacy data. Beyond neuropathy, ALA activates glucose uptake transporter GLUT4 independent of insulin, supporting peripheral glucose disposal. It regenerates depleted glutathione, vitamin C, and vitamin E, amplifying the total antioxidant network. In liver health, ALA supports mitochondrial function and has demonstrated hepatoprotective properties relevant to non-alcoholic fatty liver disease. MSVD Labs manufactures ALA capsules under WHO-GMP and ISO 9001:2015 certification in Surat. ALA is an unstable compound sensitive to oxidation and moisture; controlled-environment manufacturing preserves full potency through shelf life. Each batch is assayed for active content by HPLC. Available in 150mg, 300mg, and 600mg per capsule strengths. Custom combinations with B-vitamins, chromium, and biotin available. Private label and third-party manufacturing for B2B buyers with full documentation.